AUTHOR=Li Xuehui , Yao Xiaoying , Zhu Yuzhen , Zhang Hui , Wang Haiyan , Ma Qun , Yan Fenglian , Yang Yonghong , Zhang Junfeng , Shi Hui , Ning Zhaochen , Dai Jun , Li Zhihua , Li Chunxia , Su Fei , Xue Yin , Meng Xiangzhi , Dong Guanjun , Xiong Huabao TITLE=The Caspase Inhibitor Z-VAD-FMK Alleviates Endotoxic Shock via Inducing Macrophages Necroptosis and Promoting MDSCs-Mediated Inhibition of Macrophages Activation JOURNAL=Frontiers in Immunology VOLUME=10 YEAR=2019 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01824 DOI=10.3389/fimmu.2019.01824 ISSN=1664-3224 ABSTRACT=
Macrophages play a critical role in the pathogenesis of endotoxin shock by producing excessive amounts of pro-inflammatory cytokines. A pan-caspase inhibitor, zVAD, can be used to induce necroptosis under certain stimuli. The role of zVAD in both regulating the survival and activation of macrophages, and the pathogenesis of endotoxin shock remains not entirely clear. Here, we found that treatment of mice with zVAD could significantly reduce mortality and alleviate disease after lipopolysaccharide (LPS) challenge. Notably, in LPS-challenged mice, treatment with zVAD could also reduce the percentage of peritoneal macrophages by promoting necroptosis and inhibiting pro-inflammatory responses in macrophages.